Acurx Pharmaceuticals Inc (ACXP)

Finanzdaten der Acurx Pharmaceuticals Inc-Aktie (ACXP)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	34.45%2.31	1.72	1.62	2.03	2.27
Research and Development	213.80%1.07	0.34	0.28	0.43	0.52
Operating Income/Loss	34.45%-2.31	-1.72	-1.62	-2.03	-2.27
	34.10%-2.25	-1.68	-1.58	-1.99	-2.25
Attributable To Parent	34.10%-2.25	-1.68	-1.58	-1.99	-2.25
Basic Average Shares	56.69%4.26	2.72	-	1.63	1.19
Diluted Average Shares	56.69%4.26	2.72	-	1.63	1.19
Basic Earnings Per Share	14.52%-0.53	-0.62	-	-1.23	-1.89
Diluted Earnings Per Share	14.52%-0.53	-0.62	-	-1.23	-1.89